Carboplatin (AUC 5): clinical trials recruiting now
6
Recruiting trials
15
Conditions studied
21
US states with sites
12
Countries
Phase breakdown
Phase 1 2
Phase 2 5
Conditions being studied
Recruiting trials involving Carboplatin (AUC 5)
- A Study of Ivonescimab in First-Line ES-SCLC
- A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
- Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
- Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
Common questions
How many recruiting trials involve Carboplatin (AUC 5)?
6 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.